Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Facial Cutaneous Sarcoidosis (SIRIUS)
NCT05458492Phase 2Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sirolimus in cutaneous sarcoidosis, sponsored by Assistance publique - Hôpitaux de Paris. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
sirolimus
03
Conditions
cutaneous sarcoidosis
Beyond the preview
Go deeper on NCT05458492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05458492.